Search results for "Highlights"
SGLT2 inhibitors, GLP-1 receptor agonists compared for CV, renal outcomes
Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with fewer hospitalizations for heart failure and slower progression of kidney disease while glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk of stroke.
https://diabetes.acponline.org/archives/2019/03/08/3.htm
8 Mar 2019
Physician, practice characteristics may affect diabetes care quality
A systematic review and meta-analysis found that physicians who were female, treated diabetes more often, and used electronic health records were associated with higher-quality care in adults with diabetes.
https://diabetes.acponline.org/archives/2020/02/14/1.htm
14 Feb 2020
Poor glycemic control associated with fracture in type 1 but not type 2 diabetes
Patients with type 1 diabetes and a mean three-year HbA1c level greater than 8.0% had a higher fracture risk than those with a mean three-year HbA1c level of 7.0% or less.
https://diabetes.acponline.org/archives/2019/02/08/3.htm
8 Feb 2019
3 actions may help reluctant patients begin insulin therapy for type 2 diabetes
Patients' perceived helpfulness of certain actions by health care professionals was linked to earlier insulin initiation and greater insulin continuation over time, a survey found.
https://diabetes.acponline.org/archives/2019/02/08/2.htm
8 Feb 2019
Drug-eluting stents may not confer advantage in diabetic patients
An editorial noted that drug-eluting stents may work for noncomplex lesions in patients with diabetes, but complex disease states incurred high rates of myocardial infarction and revascularization.
https://diabetes.acponline.org/archives/2019/01/11/3.htm
11 Jan 2019
Consensus report updates evidence on managing hyperglycemia in patients with type 2 diabetes
The American Diabetes Association and the European Association for the Study of Diabetes updated their 2018 recommendations based on trials published in 2019.
https://diabetes.acponline.org/archives/2020/01/10/1.htm
10 Jan 2020
Cardiovascular event rates similar among newer second-line medications for type 2 diabetes
The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.
https://diabetes.acponline.org/archives/2019/01/11/2.htm
11 Jan 2019
SGLT2 inhibitors associated with increased risk of amputations, diabetic ketoacidosis
Sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists had similar rates of other adverse events, including bone fracture, acute kidney injury, serious urinary tract infection, venous thromboembolism, and acute pancreatitis.
https://diabetes.acponline.org/archives/2018/12/14/3.htm
14 Dec 2018
New equation with five variables helps predict hip fracture risk in type 2 diabetes
Age, sex, body mass index, peripheral sensory neuropathy, and estimated glomerular filtration rate were the included variables.
https://diabetes.acponline.org/archives/2018/12/14/2.htm
14 Dec 2018
No link between vitamin D, omega-3 fatty acid supplements and improved kidney function
An ancillary analysis of the Vitamin D and Omega-3 Trial (VITAL) included 1,312 adult patients with type 2 diabetes who agreed to additional testing of kidney function and urinary albumin excretion at baseline and two and five years after randomization.
https://diabetes.acponline.org/archives/2019/12/13/1.htm
13 Dec 2019